Follow the Marvel Biosciences Corp. Formerly Alphanco Venture Corp. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €9.8m. The latest transaction was filed on 1 September 2026 (56 - Grant of rights). Among the most active insiders: Matheson, Joseph Roderick. All data is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
30,000 shares@ CA$0.165100.0% of flowCommon SharesTSXSEDI:4764733
Canonical exit: 12 Nov 2026 (T+90)
6 of 6 declarations
About Marvel Biosciences Corp. Formerly Alphanco Venture Corp.
Marvel Biosciences Corp., formerly known as Alphanco Venture Corp., is a Toronto Stock Exchange-listed company focused on developing biopharmaceutical solutions.